Track KAPA and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
KAPA - Kairos Pharma, Ltd. (KAPA) has a earnings per share of -$0.08, down 166.7% over the past year.
Latest EPS (Actual)
-$0.08
Beat Rate
0.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| Jun 2026 | -$0.07 | -$0.08 | Miss | -14.29% |
| Mar 2026 | $0.03 | -$0.07 | Miss | -333.33% |
| Nov 2025 | -$0.07 | -$0.07 | Meet | +0.00% |
| Aug 2025 | -$0.05 | -$0.08 | Miss | -60.00% |
| Apr 2025 | -$0.02 | -$0.03 | Miss | -50.00% |
| Feb 2025 | -$0.02 | -$0.05 | Miss | -150.00% |
| Nov 2024 | -$0.02 | -$0.10 | Miss | -400.00% |
| Aug 2024 | $0.00 | -$0.02 | N/A | - |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.